Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis-Reference-Cited by-同舟云学术

Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis

Published:2021-03 Issue:3 Volume:22 Page:341-350
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ward Zachary J,Scott Andrew M,Hricak Hedvig,Atun Rifat

Funder

National Cancer Institute

Harvard T.H. Chan School of Public Health

Publisher

Elsevier BV

Subject

Oncology

Reference27 articles.

1. Global Cancer Observatory: Cancer today;Ferlay,2020

2. Global cancer transitions according to the Human Development Index (2008–30): a population-based study;Bray;Lancet Oncol,2012

3. Expansion of cancer care and control in countries of low and middle income: a call to action;Farmer;Lancet,2010

4. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018

5. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries;Canfell;Lancet,2020

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of infrared spectroscopy in the field of tumor;Infrared Spectroscopy - Biotechnological Applications [Working Title];2024-09-11

2. Cancer incidence and survival for 11 cancers in the Commonwealth: a simulation-based modelling study;The Lancet Oncology;2024-09

3. Cancer survival statistics in China 2019–2021: a multicenter, population-based study;Journal of the National Cancer Center;2024-09

4. Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021;eClinicalMedicine;2024-09

5. The prognostic significance of lncRNA FGD5-AS1 in various malignancies: a meta-analysis;Frontiers in Oncology;2024-08-19